Cambridge, Mass., Pubic Health Dept. Seeks to Bar Creation of New Biosafety Level 4 Labs | GenomeWeb

By Alex Philippidis

Eager to avoid the controversy associated with the development of a biodefense lab in neighboring Boston, as well as to plug what it considers a loophole in current law, the Cambridge, Mass., Public Health Department is working to legally bar the creation of new Biosafety Level 4 laboratories that carry out research on the deadliest pathogens.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.